Biocopy is breaking new ground in finding cures for cancer with an AI-driven platform
Total raised: $20.21M
Funding Rounds 2
| Date | Series | Amount | Investors |
| 01.05.2026 | - | $11.53M | - |
| 20.03.2025 | - | $8.68M | - |
Mentions in press and media 7
| Date | Title | Description |
| 01.05.2026 | BioCopy raises CHF 9 million for bispecific antibody pipeline | BioCopy is a Swiss-German biotech company with headquarters in Basel and an R&D facility in Emmendingen, Germany. The company combines proprietary ultra-high-throughput screening technologies, artificial intelligence and wet-lab experi... |
| 21.03.2025 | Flexvelop's Leap: A FinTech Transformation Fueled by €44 Million Investment | In the bustling world of FinTech, where innovation meets necessity, Flexvelop has emerged as a beacon of change. This Hamburg-based startup, founded in 2018, has recently secured a substantial €44 million in funding. This investment marks a... |
| 21.03.2025 | The Future of Medicine: AI and Biotech Revolutionize Diagnostics and Drug Development | In the realm of healthcare, change is the only constant. Two recent breakthroughs illustrate this truth vividly. One focuses on sleep disorders linked to Parkinson's disease, while the other aims to revolutionize cancer drug development. Bo... |
| 21.03.2025 | 8 Millionen für Biotech-Startup BioCopy | BioCopy beabsichtigt wirksamere Krebsmedikamente in kürzester Zeit und zu deutlich niedrigeren Kosten herzustellen. Im Fokus steht die Entwicklung von Biotherapeutika der nächsten Generation gegen Lungen-, Blasen- und Ovarialkarzinome. «Mi... |
| 20.03.2025 | BioCopy raises €8M to cut cancer drug development from years to months | The German-Swiss biotech BioCopy has secured €8 million in funding. BioCopy focuses on the discovery and development of biotherapeutic drugs using an automated, AI-assisted end-to-end platform and is developing next-generation biotherapeuti... |
| 20.03.2025 | Flexvelop erhält 44 Millionen – buynomics sammelt 30 Millionen ein – theion bekommt 15 Millionen | Im #DealMonitor für den 20. März werfen wir einen Blick auf die wichtigsten, spannendsten und interessantesten Investments und Exits des Tages in der DACH-Region. Alle Deals der Vortage gibt es im großen und übersichtlichen #DealMonitor-Arc... |
| 17.07.2024 | BioCopy Chooses Genedata for AI-Powered Multispecific Antibody Discovery | Digitalizing Biopharma R&D: The Genedata Biopharma Platform is the #1 enterprise software system for achieving operational excellence in biopharma R&D. Cutting-edge biotech builds on best-in-class software to automate R&D workfl... |